Amount$15M
SeriesSeries A
AnnouncedMay 1, 2021
Time since last round277 mo
SectorLife Sciences, Immunotherapy, Immunology, Cancer, Cancer Immunotherapy, Antibody
Sub-sectorArtificial Intelligence
Strong
A strong, well-structured round.
Round size vs peers
In line with the typical Series A round.
Syndicate size
Single investor — limited external validation.
Insider conviction
1 existing investor re-upped — insiders doubling down.
Investor track record
A mix of established and emerging investors.
Heuristic read of round size vs peers, syndicate size, insider conviction, and investor track record. Not investment advice.
vs. Series A rounds (995)
Round size distribution59th pct
smaller Series A roundslarger
vs. Life Sciences, Immunotherapy, Immunology, Cancer, Cancer Immunotherapy, Antibody (6)
Round size in sector83th pct
$3Mthis round: $15M$25M
